NCT05438056 is a NA clinical trial of education with mobile application in Mother, sponsored by Ankara University.

Who is sponsoring NCT05438056?

NCT05438056 is sponsored by Ankara University.

What drugs are being tested in NCT05438056?

Interventions in NCT05438056: education with mobile application.

What condition does NCT05438056 study?

NCT05438056 studies Mother, Premature, Education, Home Care, Mobile Application.

Is NCT05438056 still recruiting?

NCT05438056 is currently status unknown. Last updated 1 July 2022.

Last reviewed 2022-07-01 · How we verify

NCT05438056

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of the Mobile Application Developed for Home Care of Preterm

Status unknown NA Last updated 1 July 2022

What this trial tests

NA trial testing education with mobile application in Mother in 48 participants. Status unknown.

Timeline

16 December 2022

Primary endpoint
30 August 2023

30 December 2023

Quick facts

Lead sponsor	Ankara University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	48
Start date	16 December 2022
Primary completion	30 August 2023
Estimated completion	30 December 2023

Drugs / interventions tested

education with mobile application

Conditions studied

Mother — all drugs for Mother →
Premature — all drugs for Premature →
Education — all drugs for Education →
Home Care — all drugs for Home Care →

Sponsor

Ankara University

Who can join

18 and older, female only, with Mother or Premature. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

mobile application will be developed to support the post-discharge home care of mothers of premature babies. With the developed mobile application, the effect of the education given to the mothers on the knowledge and skills of infant care, mother-infant attachment, and the mother's self-efficacy will be evaluated.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Ankara University trials

Trials by the same sponsor.

NCT07441837 — Terbium 161 PSMA in Lutetium-177 PSMA Naive Patients · Phase 2 · not yet recruiting
NCT07536490 — Sleep Quality, Cognition, and Disease Severity in Parkinson's Disease · not yet recruiting
NCT06959433 — Lu-177 PSMA Treatment in Cell Renal Carcinoma · Phase 3 · not yet recruiting
NCT07513272 — EFFECT OF BALLS ON PAIN AND ANXIETY DURING VENIPUNCTURE IN CHILDREN · NA · not yet recruiting
NCT07536542 — Effects of Dual-Task Training on Upper Extremity Function in Parkinson's Disease · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05438056 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ankara University
Last refreshed: 1 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05438056.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing